Zynex Inc. announced it has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor. The company aims to contribute to the earlier detection of sepsis, which is a critical global health issue with a high mortality rate. The new technology is designed to continuously monitor multiple physiological signals to provide real-time alerts to clinicians, potentially reducing the mortality rate associated with this condition.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。